metastatic nasopharyngeal carcinoma - Globe Thesis

Keyword [metastatic nasopharyngeal carcinoma] Result: 1 - 20 \| Page: 1 of 2
1.	Determination Of Quantitative Analysis Of Plasma Epstein-Barr Virus DNA Levels For The Patients With Recurrent And Metastatic Nasopharyngeal Carcinoma Before And After Chemotherapy
2.	Clinical Study Of Different Chemotherapy Regimens For Metastatic Nasopharyngeal Carcinoma
3.	The Clinical Observation Of Gemcitabine Plus Vinorelbine For Second-Line Treatment Of Metastatic Nasopharyngeal Carcinoma
4.	Influence Of Metastin On The Capacity Of Metastasis And Invasion In Highly Metastatic Nasopharyngeal Carcinoma SUNE-1-5-8F Cells
5.	Intervention Study Of KiSS-1 Gene Knockout On The Metastatic Behavior Of Human Low Metastatic Nasopharyngeal Carcinoma Cell Line
6.	Survival Outcomes Of Patients With Metastatic Nasopharyngeal Carcinoma Based On Intensity-modulated Radiotherapy
7.	Proteomic Comparison Based On PET/CT Defined Metabolic Tumor Volume In Non-metastatic Nasopharyngeal Carcinoma
8.	Analysis Of The Efficacy And Safety Of TP Or GP Regimen In The Treatment Of Recurrent Metastatic Nasopharyngeal Carcinoma
9.	Systemic Immune-inflammation Index As A Prognostic Marker In Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma:A Propensity Score-matched Study
10.	Clinical Observation Of Apatinib Combined With GP Regimen In The Treatment Of Recurrent Or Metastatic Nasopharyngeal Carcinoma
11.	Clinical Observation Of Apatinib Plus S-1As Posterior Line Treatment In Patients With Metastatic Nasopharyngeal Carcinoma
12.	Analysis Of The Efficacy And Cost Of GP And DP Regimen In The Treament Of Advanced Metastatic Nasopharyngeal Carcinoma
13.	Characteristics And Prognostic Factors Of Metastatic Nasopharyngeal Carcinoma Patients After Intensity-Modulated Radiotherapy
14.	Research On The Prognostic Significance Of Systemic Immune-inflammation Index And Tumor Infiltrating Lymphocytes In Nasopharyngeal Carcinoma
15.	Modified Reduced-volume Intensity-modulated Radiation Therapy In Non-metastatic Nasopharyngeal Carcinoma
16.	Expression Of Ki67 And ERCC1 In Metastasis And Clinical Significance In First-line Treatment Of Metastatic Nasopharyngeal Carcinoma
17.	The Efficacy Of Resistance To Anti-PD-1 Combined With Palliative Radiotherapy For Recurrent Or Metastatic Nasopharyngeal Carcinoma
18.	Effects Of Oral Maintenance Chemotherapy And Predictive Value Of Circulating EBV DNA In Metastatic Nasopharyngeal Carcinoma
19.	Oral Maintenance Chemotherapy Using S-1/Capecitabine In Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy:A Single Institution Experience
20.	The Value Of Lactate Dehydrogenase In Metastatic Nasopharyngeal Carcinoma
<<First <Prev Next> Last>> Jump to